Antibody and CD8+ T Cell Responses: How the Delta Variant Evades Immunity?

SARS-CoV-2 vaccines have reduced efficiency against variants of concern. Find out how antibody and T cell responses are affected by variant associated mutations.

mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies

Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition

Immunity in Omicron SARS-CoV-2 breakthrough COVID-19 in vaccinated adults

Evaluation of SARS-CoV-2-Specific T-Cell Activation with a Rapid On-Chip IGRA

Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants

CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques

Antibody and CD8+ T Cell Responses: How the Delta Variant Evades Immunity?

State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation

Targeting Multiple Conserved T-Cell Epitopes for Protection against COVID-19 Moderate-Severe Disease by a Pan-Sarbecovirus Vaccine

Immunity to SARS‐CoV‐2 induced by infection or vaccination - Castro Dopico - 2022 - Journal of Internal Medicine - Wiley Online Library

Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity